CK
Cory Kasimov Evercore ISI Group Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
18
Avg Return
Past Year
Past Year
14%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
82.4%
Neutral
17.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $45 |
42%
upside
| 1 | +2.4% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $125 |
71%
upside
| 1 | +4% |
0
%
| 25 Feb ‘26 2 months ago |
|
|
|
In-Line
Downgraded
| $115 |
0%
downside
| 1 | – |
–
| 24 Feb ‘26 2 months ago |
|
|
|
Outperform
Maintained
| $18 |
74%
upside
| 2 | +40% |
0
%
| 24 Feb ‘26 2 months ago |
|
|
|
In-Line
Maintained
| $35 |
31%
downside
| 2 | – |
–
| 17 Feb ‘26 2 months ago |
|
|
|
Outperform
Maintained
| $875 |
16%
upside
| 1 | +1.1% |
0
%
| 22 Jan ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $40 |
70%
upside
| 2 | +59% |
0
%
| 16 Dec ‘25 4 months ago |
|
|
|
Outperform
Initiated
| $55 |
202%
upside
| 1 | -42% |
0
%
| 26 Nov ‘25 5 months ago |
|
|
|
Outperform
Initiated
| $35 |
29%
upside
| 1 | +17% |
0
%
| 24 Nov ‘25 5 months ago |
|
|
|
Outperform
Initiated
| $25 |
144%
upside
| 1 | +6.8% |
0
%
| 20 Nov ‘25 5 months ago |
|
|
|
Outperform
Initiated
| $40 |
330%
upside
| 1 | -63% |
0
%
| 18 Nov ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $80 |
22%
upside
| 1 | +20% |
0
%
| 3 Sep ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $34 |
54%
upside
| 1 | -42% |
0
%
| 12 Aug ‘25 8 months ago |
|
|
|
Outperform
Initiated
| $55 |
0%
downside
| 1 | +85% |
0
%
| 14 May ‘25 11 months ago |
|